4.23
Schlusskurs vom Vortag:
$4.04
Offen:
$4.01
24-Stunden-Volumen:
34,671
Relative Volume:
0.46
Marktkapitalisierung:
$285.86M
Einnahmen:
$64.49M
Nettoeinkommen (Verlust:
$-71.40M
KGV:
-3.8807
EPS:
-1.09
Netto-Cashflow:
$-52.00M
1W Leistung:
+1.68%
1M Leistung:
+35.58%
6M Leistung:
+46.37%
1J Leistung:
+24.96%
Sophia Genetics Sa Stock (SOPH) Company Profile
Firmenname
Sophia Genetics Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SOPH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SOPH
Sophia Genetics Sa
|
4.23 | 282.48M | 64.49M | -71.40M | -52.00M | -1.09 |
![]()
VEEV
Veeva Systems Inc
|
287.65 | 46.89B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
89.87 | 16.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
67.03 | 12.64B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
94.04 | 8.03B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
36.62 | 6.90B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-18 | Eingeleitet | Craig Hallum | Buy |
2024-08-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2024-06-27 | Eingeleitet | Guggenheim | Buy |
2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
2023-01-03 | Eingeleitet | BTIG Research | Buy |
2022-11-23 | Eingeleitet | Credit Suisse | Neutral |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2021-08-17 | Eingeleitet | Cowen | Outperform |
2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
2021-08-17 | Eingeleitet | JP Morgan | Overweight |
2021-08-17 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten
Using flow based indicators on SOPHiA GENETICS SAPortfolio Return Summary & Verified Swing Trading Watchlists - newser.com
Biotech Stocks Surge After Hours On Trial Updates, Data Momentum - Nasdaq
Applying big data sentiment scoring on SOPHiA GENETICS SAJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Is SOPHiA GENETICS SA (90B) stock in buy zone after pullbackWeekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-13 07:16:54 - newser.com
SOPHiA GENETICS SA stock momentum explainedJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Real time scanner hits for SOPHiA GENETICS SA explainedEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
Has SOPHiA GENETICS SA found a price floorJuly 2025 Highlights & Smart Swing Trading Alerts - newser.com
Pattern recognition hints at SOPHiA GENETICS SA upsideEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
SOPHiA GENETICS SA expected to post a loss of 24 cents a shareEarnings Preview - TradingView
What catalysts could drive SOPHiA GENETICS SA stock higherMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com
Why SOPHiA GENETICS SA stock is rated strong buy2025 Analyst Calls & Capital Protection Trading Alerts - newser.com
Is SOPHiA GENETICS SA 90B a good long term investmentSupport Level Holds & Rapid Capital Growth - earlytimes.in
Weiss Ratings Reaffirms Sell (D-) Rating for SOPHiA GENETICS (NASDAQ:SOPH) - Defense World
Critical Review: Movano (NASDAQ:MOVE) and SOPHiA GENETICS (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS SA 90B Stock Analysis and ForecastMarket Sentiment Indicators & Register for the Next Free Workshop - earlytimes.in
What data driven models say about SOPHiA GENETICS SA’s futureMarket Movers & Accurate Intraday Trade Tips - newser.com
Can you recover from losses in SOPHiA GENETICS SAJuly 2025 Gainers & Real-Time Buy Zone Alerts - newser.com
Visual analytics tools that track SOPHiA GENETICS SA performanceQuarterly Portfolio Summary & Proven Capital Preservation Tips - newser.com
Momentum divergence signals in SOPHiA GENETICS SA chartMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com
What recovery options are there for SOPHiA GENETICS SAEarnings Risk Report & Weekly Top Stock Performers List - newser.com
How SOPHiA GENETICS SA (90B) stock benefits from digital adoptionWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Is SOPHiA GENETICS SA stock undervalued vs historical averages2025 EndofYear Setup & Stock Portfolio Risk Control - newser.com
How to integrate SOPHiA GENETICS SA into portfolio analysis toolsEntry Point & Stepwise Trade Signal Implementation - newser.com
What high frequency data says about SOPHiA GENETICS SAMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com
What drives SOPHiA GENETICS SA 90B stock priceDebt-to-Equity Ratio Analysis & Low Risk Trading Ideas - earlytimes.in
SOPHiA GENETICS SA Trends on Nasdaq 100 Index Performance - Kalkine Media
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores - Benzinga
How SOPHiA GENETICS SA (90B) stock behaves in tightening cyclesMarket Activity Summary & Capital Efficiency Focused Strategies - newser.com
Is now a turning point for SOPHiA GENETICS SAMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Can machine learning forecast SOPHiA GENETICS SA recoveryStop Loss & Low Drawdown Investment Strategies - newser.com
Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):